ArticleEMBO molecular medicine2017

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.

Gabriele Picco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.